Monsanto rejects $62-billion Bayer bid, but says it’s still open to talks
Monsanto is rejecting Bayer’s $62-billion takeover bid, calling it “incomplete and financially inadequate.
However, the seed company suggested Tuesday that a higher bid might be accepted, saying that it remains open to talks.
Monsanto Co. Chairman and Chief Executive Hugh Grant also said in a release that the initial offer failed to address potential financing and regulatory risks.
Bayer, a German drug and chemicals conglomerate, made an all-cash bid that valued Monsanto’s stock at $122 a share.
A combination of the two businesses would create a giant seed and farm chemical company with a strong presence in the U.S., Europe and Asia.
MORE FROM BUSINESS
Totally Worth It
Be your money's boss! Learn how to make a budget and take control of your finances with this eight-week newsletter course.
You may occasionally receive promotional content from the Los Angeles Times.